

FDA issued a warning letter dated 8 June 2026 to Maximus Health, Inc. dba Maximus (reference MARCS-CMS 730095), after reviewing maximustribe.com in May 2026. Among the cited violations, the site claimed its compounded drug products were sourced from "FDA approved pharmacies". The FDA's position is unambiguous: compounding facilities "are not 'FDA-approved' or 'FDA-licensed' entities. The FD&C Act does not establish an 'FDA-approved' or 'FDA-licensed' designation for pharmacies or outsourcing facilities", so the claim is false and misleading and misbrands the products.
A warning letter is not a finding of harm and does not mean the medication you receive is unsafe. It is a regulator formally telling a company that specific claims on its website broke the law. We report it because it is a matter of public record, it is verifiable at the source, and it is the kind of thing that never appears in a provider's own marketing.
How we make money. GLP-1 Planet earns a commission if you sign up through the links on this page. That does not change what we write, but you should know it before you read on. See our affiliate disclosure.
These plans are compounded, not FDA-approved. Maximus's headline pricing covers compounded semaglutide and tirzepatide, mixed by licensed US pharmacies. Compounded drugs are overseen by state boards of pharmacy and are not reviewed or approved by the FDA for safety, efficacy or quality. They share an active ingredient with the branded products, but they are not the same product and are not interchangeable with them.
Where the weight-loss numbers come from. The figures quoted across the industry come from trials of the branded drugs, not compounded copies and not this provider's patients. In STEP 1, adults with a BMI of 30+ (or 27+ with a weight-related condition and no diabetes) taking semaglutide 2.4 mg lost a mean of 14.9% of body weight over 68 weeks. In SURMOUNT-1, a comparable population taking tirzepatide 15 mg lost a mean of 20.9% over 72 weeks. Your results may differ, and no provider can promise a specific outcome.
Who should not take these medications. GLP-1 and GIP/GLP-1 drugs carry a boxed warning for thyroid C-cell tumors and should not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. They are not for use in pregnancy or while trying to conceive, and need careful discussion if you have had pancreatitis, gallbladder disease, severe gastrointestinal disease or diabetic retinopathy. Common side effects include nausea, vomiting, diarrhea, constipation, reduced appetite, headache and fatigue.
This review is informational only and is not medical advice. Talk to a licensed clinician before starting, stopping or changing any treatment.
Maximus is a highly-rated GLP-1 medication provider offering both semaglutide and tirzepatide for weight loss. With a 8.3/10 rating, Maximus maintains a strong reputation in the telemedicine industry. With a monthly price of $150, Maximus positions itself as a mid-range provider in the competitive GLP-1 market.
The platform offers a solid combination of medical expertise and convenient service. Offering both Maximus tirzepatide and semaglutide as part of their Maximus GLP-1 medication program gives patients and their healthcare providers flexibility to choose the best treatment based on individual needs and response. Whether you've been researching Maximus reviews, Maximus reviews complaints, or asking "is Maximus legit," you'll find that Maximus delivers legitimate, high-quality telemedicine services with licensed healthcare providers.
Maximus does not publish a customer phone number on its website; support runs through your account, not published. Maximus operates with full transparency, HIPAA compliance, and a commitment to helping patients achieve their weight loss goals safely and effectively.
After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.
The $150 monthly fee positions Maximus in the mid-range of GLP-1 providers, balancing affordability with comprehensive service.
Fill out a comprehensive medical questionnaire about your health history, weight loss goals, and current medications.
A licensed healthcare provider reviews your information and determines if GLP-1 medication is right for you.
Your prescription is shipped directly to your door with clear instructions and ongoing support.
Semaglutide (brand names Wegovy and Ozempic) is a GLP-1 receptor agonist that has been shown to help people lose an average of 15% of their body weight. It works by reducing appetite, slowing digestion, and helping you feel full longer. Maximus's standard plans use a compounded version of this ingredient, which is not FDA-approved.
Tirzepatide (brand names Mounjaro and Zepbound) is a dual GIP/GLP-1 receptor agonist that has demonstrated even more significant weight loss results, with clinical trials showing an average of 20% body weight reduction. It offers a dual-action approach to weight management. Maximus's standard plans use a compounded version of this ingredient, which is not FDA-approved.
Maximus is particularly well-suited for:
Not published on their website
Support through your account
Not available
Not published
None published - no refund policy exists on the site
Not published
Maximus is a cash-pay service and does not bill insurance. The company does not publish whether HSA or FSA cards are accepted, so check before you sign up if you plan to pay that way.
Yes, Maximus is a legitimate telemedicine provider offering GLP-1 medications for weight loss. Maximus operates with licensed healthcare providers and follows all regulatory requirements for prescribing and dispensing medications. With a 8.3/10 rating, Maximus maintains a solid reputation in the telemedicine industry.
Many people ask "is Maximus legitimate?" or "is Maximus a scam?" - these concerns are natural when considering online healthcare services. However, Maximus is a fully legitimate medical service that employs licensed physicians, maintains HIPAA compliance, and dispenses medication through licensed US pharmacies. Note that its standard plans are compounded preparations, which are not FDA-approved - a legal category of medicine, but not the same thing as the branded drug.
Maximus offers both semaglutide and tirzepatide (Maximus tirzepatide is available as part of their comprehensive GLP-1 medication program). Maximus GLP-1 medications include:
Both Maximus GLP-1 options are available at the competitive price of $150/month, making them accessible for most patients seeking weight loss treatment.
You can reach Maximus through multiple channels:
The Maximus customer support team is available Not published to answer your questions about their GLP-1 weight loss programs.
When researching "Maximus reviews," it's important to look at multiple sources. Here's what we found about Maximus reviews and complaints:
Maximus has earned a strong 8.3/10 rating based on pricing, service quality, medication options, and customer support. This places Maximus among the highly-rated GLP-1 providers in the market.
Like any healthcare provider, some customers search for "Maximus reviews complaints" or "Maximus reviews and complaints" to understand potential issues. Here's what the public record shows:
When searching for "Maximus reviews Consumer Reports" or "Maximus reviews consumer reports complaints," remember that independent review platforms provide valuable insights. Maximus's rating of 8.3/10 reflects consistent positive feedback across multiple evaluation criteria.
Whether you're searching for "Maximus reviews" or "Maximus reviews complaints," our comprehensive analysis shows that Maximus delivers on its promises of high-quality GLP-1 weight loss medication with excellent customer support.
If Maximus is not the right fit, these providers are the closest comparisons on medication and price. Each links to its own review, or you can put the two side by side.
What the trials actually showed, how the two drugs differ, and which one suits which patient.
What compounded actually means, why the price gap has narrowed, and the questions to ask first.
Every pricing model in the market, decoded - and why the advertised number is rarely the real one.
The BMI thresholds, the contraindications that rule people out, and what providers actually check.
This review is editorial research, not medical advice. GLP-1 medications are prescription drugs with real risks and contraindications, and nothing here should be used to decide whether to start, stop or change a treatment. Only a licensed clinician who knows your history can tell you whether Maximus - or any GLP-1 medication - is appropriate for you. If you think you are having a serious reaction to a medication, contact a healthcare professional or emergency services.
Prices, policies and medication availability change often in this market. We report what Maximus published on its own site at the time of review; confirm the current terms with the provider before you buy.